Hope therapeutics™, inc. and nrx pharmaceuticals, inc. (nasdaq:nrxp) engage btig as financial advisor

Hope has announced plans to assemble a best-in-class global network of interventional psychiatry clinics combining ketamine treatment with transcranial magnetic stimulation, and digital therapeutics to treat severe depression and ptsd btig is a leading global financial services firm specializing in investment banking, institutional trading, research, and related brokerage services advisory to include identification and evaluation of clinic partners and strategic assets and investment banking services in connection with financing initiatives to accelerate the company's business plan miami , feb. 3, 2025 /prnewswire/ -- hope therapeutics™, inc. ("hope"), a medical and technology driven company, and a wholly-owned subsidiary of nrx pharmaceuticals, inc. ("nrx", and collectively with hope, the "company") (nasdaq:nrxp), today announced engagement of btig, a leading global financial services firm specializing in investment banking, institutional trading, research and related brokerage services.  the scope of the engagement includes advisory and assistance in evaluating strategic and financing options available to the company and identification, evaluation and negotiation of potential acquisition targets for the hope network of clinics, as well as equity and debt financing structures.
NRXP Ratings Summary
NRXP Quant Ranking